PS2-083 Immunization with a novel dc-targeting lentiviral vector induces polyfunctional cd8 t cell responses and therapeutic anti-tumor immunity
Scott H. Robbins(TRIA Bioscience (United States)), Thomas W. Dubensky(Aduro BioTech (United States)), B. Kelley Clarke(Metis Design Corporation (United States)), C.J. Nicholai(Metis Design Corporation (United States)), David Baltimore(California Institute of Technology), Megan M. Slough(Metis Design Corporation (United States)), Semih U. Tareen(Metis Design Corporation (United States)), Jared Odegard(Gilead Sciences (United States)), Steven G. Reed(Infectious Disease Research Institute), Chintan D. Vin(Metis Design Corporation (United States)), D. J. Campbell(Metis Design Corporation (United States)), Neal Van Hoeven(Sana Biotechnology (United States))
Cited by 0
Related Papers
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k
Key roles of adjuvants in modern vaccines
|Nature Medicine|2013|1.4k
<i>ATR</i> disruption leads to chromosomal fragmentation and early embryonic lethality
|Genes & Development|2000|944
Circuitry of nuclear factor κB signaling
|Immunological Reviews|2006|895
<i>miR-146a</i> is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
|The Journal of Experimental Medicine|2011|865